Replies to post #16459 on Momenta Pharmaceuticals, Inc. (MNTA)

[DewDiligence]

TEVA loses 40mg-Copaxone patent case—Bloomberg:

https://twitter.com/CarolineYLChen/status/826198760514605057

This is a big win for MNTA, although it's not that surprising for the reason mentioned in #msg-125465255.